Aleix Prat (Hospital Clínic-UB) and Patricia Villagrasa-González (Reveal Genomics).
The University of Barcelona has become a shareholder of Reveal Genomics, a spin-off of Hospital Clínic and Vall d'Hebron Institute of Oncology (VHIO), which plans to develop and market precision diagnostic tools in oncology based on he combination of different genomic data. First, the spin-off will focus on the improvement of breast cancer diagnosis with tools that enable them to personalize the treatment of the disease.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
